ArticleChemical science2026
A unified cobalt-electrocatalytic platform for enantio- and stereo-selective C-H and C-F functionalization of
Abstract read
In one paragraph
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Jiating CaiGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.
Xinyu GaoGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.
Chuitian WangGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.
Yang LiGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.
Xiaoxin TongGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.
Linzai LiGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.
Shi QinGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.
Mingkai YangGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.
Qixin LiGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.
Wei WeiGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.
Lei MaGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.
Mei WangGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.
Si-Yan LiaoGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.
Yugang HuangGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.ORCID https://orcid.org/0000-0001-8883-2431
Xin ZhaoGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.ORCID https://orcid.org/0000-0001-5679-2068
Shengdong WangGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.ORCID https://orcid.org/0000-0001-7431-2515
Zhi ZhouGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.ORCID https://orcid.org/0000-0002-6521-8946
Hui GaoSchool of Traditional Chinese Medicine and Health, Nanfang College Guangzhou Guangzhou Guangdong 510970 China.ORCID https://orcid.org/0000-0002-8736-4485
Wei YiGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.ORCID https://orcid.org/0000-0001-7936-9326
Zhongyi ZengGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University Guangzhou Guangdong 511436 China wangm0529@163.com yiwei@gzhmu.edu.cn zzeng@gzhmu.edu.cn.ORCID https://orcid.org/0000-0003-3366-7592
Funding
No grant is acknowledged in the PubMed record.
Abstract
While the merger of electrochemistry with enantioselective C-H functionalization has opened new avenues for assembling valuable chiral architectures, the simultaneous cleavage of strong C-H and C-F bonds
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.